TickerFacts.

Bioharvest Sciences Inc. (BHST): Operating Income

Annual figures by period end, from SEC filings.

-$5.58M
Year ended 2025-12-31
2023-12-31: -$9.97M2024-12-31: -$6.99M2025-12-31: -$5.58M-$5.58M
2023-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$5.58Mn/m2026-03-31, From 2025-01-01
2024-12-31-$6.99Mn/m2026-03-31, From 2024-01-01
2023-12-31-$9.97Mn/a2025-03-31, From 2023-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Bioharvest Sciences Inc. (BHST)2025-12-31-$5.58Mn/m
Verrica Pharmaceuticals Inc. (VRCA)2025-12-31-$12.19Mn/m
Sunshine Biopharma Inc. (SBFM)2025-12-31-$6.23Mn/m
Lftd Partners Inc. (LIFD)2025-12-31$913.2Kn/m
Zomedica Corp. (ZOMDF)2025-12-31-$84.35Mn/m
BGM Group Ltd. (BGM)2025-09-30-$12.58Mn/m
Verastem, Inc. (VSTM)2025-12-31-$170.13Mn/m
Foghorn Therapeutics Inc. (FHTX)2025-12-31-$86.39Mn/m
Biofrontera Inc. (BFRI)2025-12-31-$11.35Mn/m

Compare BHST, VRCA, SBFM, LIFD side by side · Screen every company in Pharmaceutical Preparations ↗